Upcoming event: 2nd Conference of the European Association of Systems Medicine – 7-9 November 2018 – Utrecht, NL

The European Association of Systems Medicine (EASyM) is organising the second International Conference on Systems Medicine entitled “Big Data: transition to practice”, which will give delegates a flavour of cutting edge research and translation of it to the clinics within the field. The conference is designed to initiate and promote interactions between researchers and clinicians who are interested in applying systems level approaches to address medical problems.

The conference will take place from 7 to 9 November 2018 in Utrecht, the Netherlands which is famous for its medieval old town (the iconic Domtoren), canals, Christian monuments and a venerable university. The meeting location will be the Muntgebouw (‘Mint Building’).

An application will be made to the EACCME® for CME accreditation of this event.

More information can found here.

MEL-PLEX Conference

On May 2018 the MEL-PLEX Consortium will host its final meeting with invited keynote experts in melanoma research from signalling to transnational medicine and the latest advances in the clinic.

The conference will be hosted in Fiuggi, Italy as a satellite event of the European Workshops on Cell Death (EWCD).

Fore more information contact us at melplexetn@rcsi.ie.

MEL-PLEX Conference flyer_2018

ECDO 2017 Conference

The 25th ECDO Conference will be dedicated to one of the hottest topic in biomedical and cell death research; the intersection between cell death and the immune system, which is central to physiological healing responses, key human pathologies and the development of novel therapeutics.

The Conference aims to bring together top-level international speakers and global leaders of the cell death and immunology fields together with young scientists and clinicians.

The program covers a wide range of critically important topics ranging from molecular pathways of different and emerging cell death modalities and their intersection with the innate and adaptive immunity, to the effects of dying cells on tissues repair, inflammation and microenvironment, to novel approaches harnessing immune effectors for therapeutic purposes in degenerative diseases and cancer.

For more information and registration, click here.